220 related articles for article (PubMed ID: 35709179)
1. Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.
Tang Q; Pan W; Peng L
PLoS One; 2022; 17(6):e0269995. PubMed ID: 35709179
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: a systematic review with meta-analysis.
Janicki L; Patel A; Jendrzejewski J; Hellmann A
Front Endocrinol (Lausanne); 2023; 14():1273498. PubMed ID: 38047109
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
[TBL] [Abstract][Full Text] [Related]
4. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis.
Lee JH; Kim Y; Choi JW; Kim YS
Eur J Endocrinol; 2013 Mar; 168(3):343-9. PubMed ID: 23211578
[TBL] [Abstract][Full Text] [Related]
5. Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies.
Moon S; Chung HS; Yu JM; Yoo HJ; Park JH; Kim DS; Park YJ
Endocrinol Metab (Seoul); 2018 Dec; 33(4):473-484. PubMed ID: 30513562
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.
Cai YF; Wang QX; Ni CJ; Guo GL; Li Q; Wang OC; Wu L; Du HY; You J; Zhang XH
Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study.
Nasiri S; Yazd SMM; Gholami M; Shahriarirad S; Sharghi S; Shahriarirad R
BMC Endocr Disord; 2023 Mar; 23(1):66. PubMed ID: 36964545
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Zhang Q; Liu SZ; Zhang Q; Guan YX; Chen QJ; Zhu QY
Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894
[TBL] [Abstract][Full Text] [Related]
11. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
12. Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma.
Xu J; Ding K; Mu L; Huang J; Ye F; Peng Y; Guo C; Ren C
Front Endocrinol (Lausanne); 2022; 13():801925. PubMed ID: 35282434
[TBL] [Abstract][Full Text] [Related]
13. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
[TBL] [Abstract][Full Text] [Related]
15. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
16. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.
Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B
Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630
[TBL] [Abstract][Full Text] [Related]
17. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
[TBL] [Abstract][Full Text] [Related]
18. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
19. Frequency of hashimoto thyroiditis in papillary thyroid cancer patients and its impact on their Outcome.
Batool S; Das B; Arif M; Islam N
J Ayub Med Coll Abbottabad; 2022; 34(2):251-255. PubMed ID: 35576281
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]